2nd Annual Brain Metastases Research and Emerging Therapy Conference - Marseille

Mercredi 5 septembre 2012, la 2ème édition Métastases cérébrales, sur un format de Conférence et d'organisation d'une session de Networking européen avec la présence des meilleurs experts dans le domaine, aura lieu au Palais des Arts au Parc Chanot.

Scientific program - Wednesday September 5, 2012

09.15 Welcome to participant - Coffee
09.45 Introduction, Philippe Métellus & Christian Chabannon

10.00 Pathobiology of brain metastases
CHAIRPERSONS: Dominique Figarella-Branger & Anthony Gonçalves
10.00 - 10.25 New insights in the molecular characterization of brain metastases, Matthias Preusser
10.35 – 11.00 Micro-RNA-based identification of the primary tumor tissue, Wolf C. Mueller

11.10 Targeted therapy
CHAIRPERSONS: Antoine Carpentier & Yael Mardor
11.10 - 11.35 Correlation between quantitative HER-2 protein expression and risk for brain metastases, Renata Duchnowska
11.45 - 12.10 Brain metastases in HER2+ BC and Landscape trial: . toward a change of paradigm, Thomas Bachelot

12.45 Lunch

13.15 - 14.15 Symposium on Targeted Therapies

14.15 Multimodal imaging
CHAIRPERSONS: Eric Guedj & Fabrice Barlési
14.15 – 14.40 Nuclear imaging in brain metastases:
current role in diagnosis, prognosis and monitoring, Bernd J. Krause
14.50 – 15.15 MRI changes interpretation following radiosurgical treatment of brain metastases, Bodo Lippitz
15.30 – 15.55 New imaging techniques in brain metastases diagnosis . and follow-up, Yael Mardor

16.00 Coffee break

16.30 Local treatment
CHAIRPERSONS: Bodo Lippitz & Jean Régis
16.30 – 16.55 Place of surgery in diagnostic and therapeutic strategies: New challenges, Philippe Métellus
17.00 – 17.25 Place of tumor bed radiosourgery and focal radiotherapy following resection of brain metastases: A new paradigm, Lucyna Kepkal

17.30 Neurocognitive function in Brain Metastases patients
CHAIRPERSON: Frédéric Dhermain & Agnès Richard-Tallet
17.30 – 17.55 Neurocognition in patients with brain metastases, Martin Klein

18.00 Poster session

19.30 European perspectives and collaborations
Introduction: interaction with the Industry and development of emerging targeted therapies
Round table: Open discussion on future clinical trials delineation in brain metastases, GRPCMaC driven session

21.00 End of the conference

Faculty

Dr Thomas Bachelot, Lyon, France
Pr Fabrice Barlési, Marseille, France
Dr Antoine Carpentier, Paris, France
Dr Frédéric Dhermain, Villejuif, France
Dr Renata Duchnowska, Gdansk, Poland
Pr Dominique Figarella-Branger, Marseille, France
Dr Eric Guedj, Marseille, France
Dr Lucyna Kepkal, Warsaw, Poland
Dr Martin Klein, Amsterdam, The Netherlands
Pr Bernd J. Krause, München, Germany
Pr Bodo Lippitz, London, United Kingdom
Dr Yael Mardor, Tel-Aviv, Israel
Pr Philippe Métellus, Marseille, France
Dr Wolf C. Mueller, Heidelberg, Germany
Dr Matthias Preusser, Vienna, Austria
Pr Zvi Ram, Tel-Aviv, Israel
Pr Jean Régis, Marseille, France
Dr Agnès Richard-Tallet, Marseille, France